Article Details

AstraZeneca, RenalytixAI Announce Collaboration in Cardiovascular, Renal, and Metabolic Disease

Retrieved on: 2020-08-22 20:56:15

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca, RenalytixAI Announce Collaboration in Cardiovascular, Renal, and Metabolic Disease. View article details on hiswai:

Excerpt

<div>... have announced a collaboration to use <b>artificial intelligence</b> (AI) for precision medicine strategies in cardiovascular, renal, and metabolic diseases.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo